Health economics perspective of fesoterodine, tolterodine or solifenacin as first-time therapy for overactive bladder syndrome in the primary care setting in Spain

Table 3 Percentage of patients using OAB-related concomitant medications during follow-up by antimuscarinic drug

SSRIs = selective serotonin reuptake inhibitors; SNRIs = serotonin-norepinephrine reuptake inhibitors.
*Controlling for location, age, sex, medication possession ratio, time since diagnosis and Charlson co-morbidity index.
^† P < 0.001 vs fesoterodine.
^‡ P < 0.001 vs solifenacin.
^§ P < 0.05 vs fesoterodine.
^‖ P < 0.01 vs fesoterodine.

ISSN: 1471-2490